Sorà, F. et al. 2021. IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?. Mediterranean Journal of Hematology and Infectious Diseases. 13, 1 (Oct. 2021), e2021062. DOI:https://doi.org/10.4084/MJHID.2021.062.